What to Tell Your Doctor About Medical Cannabis
The most underutilized tool in cannabis medicine is also the most basic: telling your other doctors that you use it. Patients hesitate because they fear judgment, fear it will affect their prescriptions, or simply don't know it matters. It matters — primarily because cannabis interacts with common medications in ways that change how both the cannabis and the medications work. Honest disclosure protects you. This guide explains what to tell your primary care doctor, your specialists, and your pharmacist, and what legal protections New Jersey law provides for your healthcare relationship.
Why Your Doctors Need to Know
Cannabis is pharmacologically active. That means it interacts with other pharmacologically active substances — which is what prescription medications are. The clinical reasons your doctors need to know:
Drug Interactions
Cannabis is metabolized primarily through the liver's cytochrome P450 enzyme system, particularly CYP3A4 and CYP2C9. Many common medications use the same pathways. When cannabis occupies these enzymes, it can raise or lower the effective blood levels of other drugs.
The most clinically significant interaction classes:
- Blood thinners (warfarin, Coumadin): CBD inhibits CYP2C9, the enzyme that metabolizes warfarin. CBD + warfarin can raise INR levels, increasing bleeding risk. Patients on warfarin who begin cannabis need INR monitoring. This is not theoretical — case reports of elevated INR with CBD are documented.
- Anticonvulsants (clobazam, valproate): CBD raises clobazam's active metabolite to levels requiring dose adjustment. Valproate combined with CBD increases liver enzyme elevation risk.
- Opioids: Cannabis has additive CNS depressant effects with opioids, though the combination is widely used clinically and cannabis may reduce opioid requirements over time. Your prescribing provider should know.
- Benzodiazepines (Xanax, Klonopin, Ativan, Valium): Overlapping CNS depressant effects. The combination increases sedation risk, particularly in older adults.
- Blood pressure medications: Cannabis transiently raises heart rate and can produce orthostatic hypotension; patients on antihypertensives may have exaggerated blood pressure responses.
- Immunosuppressants (tacrolimus, cyclosporine): Significant CYP3A4 interactions — cannabis can alter drug levels substantially. Patients post-transplant on immunosuppressants need disclosure and monitoring.
- Chemotherapy agents: Multiple chemotherapy drugs are CYP3A4 substrates; cannabis use in oncology patients should always be disclosed to the oncologist.
- Antidepressants and psychiatric medications: SSRIs (fluoxetine, fluvoxamine) are themselves CYP inhibitors and can alter cannabis metabolism. Interaction profiles vary by medication; your psychiatrist needs to know.
The point is not that cannabis is dangerous with other medications — it is that undisclosed cannabis use produces medication levels your providers are not accounting for. Transparency gives them the information to manage your care correctly.
Symptom Attribution
If you begin using cannabis and your symptoms change — for better or worse — your doctors cannot correctly attribute those changes unless they know you added cannabis. A pain doctor who doesn't know you started cannabis may prescribe additional opioids for pain that cannabis has already been addressing. A psychiatrist who doesn't know you started cannabis may not understand why your anxiety has changed. Accurate symptom assessment requires knowing all variables.
Surgical and Anesthesia Risk
Cannabis use affects anesthesia dosing. Regular cannabis users may require higher doses of anesthetic agents. Acute cannabis intoxication around the time of surgery affects cardiovascular stability. Anesthesiologists need to know your cannabis use before any surgical procedure.
What New Jersey Law Says About Cannabis Disclosure
Under New Jersey's CREAMMA Act (2021), licensed healthcare providers cannot discriminate against patients in medical care based solely on their status as a medical cannabis patient or their use of cannabis in compliance with state law. A doctor cannot refuse to treat you, refuse to prescribe your other medications, or take adverse clinical action against you solely because you use medical cannabis.
This means you have a legal basis for honest disclosure without fear of losing your healthcare relationship.
Exceptions: If your cannabis use is directly relevant to a specific treatment decision — for example, a surgeon who needs to know about cannabis for anesthesia purposes — that is clinical management, not discrimination. The law does not prevent providers from making clinical decisions that account for cannabis; it prevents them from punishing patients for using it.
How to Bring It Up
The practical reality: most physicians today are neither surprised by cannabis use nor hostile to it. The clinical conversation is simpler than patients usually fear.
A straightforward approach: "I'm using medical cannabis for [condition] through the NJ program. I wanted to make sure you know in case it affects any of my other medications or anything you're monitoring."
That sentence does what needs to be done: it discloses use, names the condition, flags the clinical reason you're telling them (medication interactions and monitoring), and invites the clinical response rather than a judgment response.
If your doctor reacts with judgment rather than clinical engagement, that is worth noting — it may reflect a communication style mismatch rather than bad medicine, but it is a signal about the care relationship.
What to say to a pharmacist: Pharmacists run drug interaction checks on every prescription they fill, but only against medications in your profile. Cannabis is not in your prescription profile. Telling your pharmacist you use cannabis allows them to run interaction checks against the full picture of what you are taking. Pharmacists are typically the most accessible healthcare professional and often the most practically knowledgeable about drug interactions — use them.
HIPAA and Privacy
What your doctor records about your cannabis use in your medical chart is protected by HIPAA the same as any other health information. Your employer cannot access your medical records. Your insurance company cannot demand to see your prescription history for non-insurance-related purposes.
Your state medical cannabis registration is separate from your private medical records. The NJ NJMCP maintains a patient registry; that information is accessible to law enforcement in limited circumstances (verifying patient status during a traffic stop, for example) but is not shared with employers or insurance companies under normal circumstances.
Note: If you have federal employment, a security clearance, or work in a safety-sensitive role regulated by the DOT, federal drug testing and related requirements operate under different rules than HIPAA. See a qualified attorney if any of those apply to you.
Specific Situations That Require Disclosure
Before surgery or a procedure requiring anesthesia: Always disclose. The risk of not disclosing is adverse cardiovascular events or under-anesthesia during a surgical procedure. This is not a risk worth taking for privacy reasons.
Before starting a new prescription: Always mention it. Any new prescription enters the drug interaction picture.
During pregnancy: The PremierMD team will counsel you on cannabis and pregnancy if relevant. The NJ NJMCP evaluates whether certification is appropriate during pregnancy on an individual clinical basis. Your OB/GYN needs to know.
If you are on anticoagulation (warfarin/INR monitoring): Disclose to your prescribing physician immediately when you start cannabis. Request INR monitoring at closer intervals until your levels stabilize.
If you are a blood pressure or cardiovascular patient: Disclose to your cardiologist or PCP. Cannabis's cardiovascular effects (acute tachycardia, blood pressure variability) are relevant to your monitoring plan.
Frequently Asked Questions: Disclosing Cannabis to Your Doctor
Can my doctor refuse to see me if I use cannabis?
Under CREAMMA, a licensed healthcare provider cannot refuse to treat you solely because you are a medical cannabis patient. Refusal to treat solely on that basis would be subject to challenge under New Jersey anti-discrimination law.
Can cannabis use affect my health insurance?
Life insurance applications ask about drug use; answers affect coverage and premiums, and the specifics depend on the insurer and policy. Health insurance under the ACA is not permitted to discriminate based on medical history or health status. Consult your insurance agent or attorney if you have concerns about a specific policy.
Do I have to disclose cannabis use when applying for a new doctor?
Medical intake forms ask about medications and substance use. Honest answers give your new provider accurate information and protect you from adverse drug interactions. Inaccurate intake information creates clinical risk.
What if I prefer CBD-only products — does that still need disclosure?
Yes. CBD is pharmacologically active and has documented drug interactions, particularly with warfarin, anticonvulsants, and immunosuppressants. "CBD-only" does not mean "clinically inert."
Get Evaluated at PremierMD
If you are considering medical cannabis and want a physician who can guide both the certification and the conversation with your other providers, check your eligibility or register as a patient.
